First Choice Neurology

Medicare to Restrict Coverage of Anti-Amyloid Antibody Therapy for Alzheimer’s Patients

By Jeffrey Gelblum, MD As a practicing neurologist with over 25 years’ experience treating Alzheimer’s disease, I strongly oppose the proposed intention of Centers for Medicare & Medicaid Services (CMS) to restrict coverage of anti-amyloid antibody therapy only those patients who must participate in an approved hospital-based clinical trial (Coverage with Evidence Development, CED). This …

Medicare to Restrict Coverage of Anti-Amyloid Antibody Therapy for Alzheimer’s Patients Read More »

What You Need to Know About the Rapidly Spreading Omicron Variant

Omicron (B.1.1.529) is now in most states and is rapidly increasing the number of COVID-19 cases. The CDC expects that anyone with Omicron infection can spread the virus to others, even if they are vaccinated or don’t have symptoms. According to the CDC, about 73% of the new COVID cases in the U.S. are caused …

What You Need to Know About the Rapidly Spreading Omicron Variant Read More »

World Alzheimer’s Day: Alzheimer’s, Dementia, and the Brain

Today is World Alzheimer’s Day. It’s a day to celebrate to create awareness about the disease and to reduce the stigmatization and lack of information surrounding dementia. While World Alzheimer’s Month offers a longer period of time for Alzheimer’s or dementia associations worldwide to raise awareness, World Alzheimer’s Day marks the focal point of the …

World Alzheimer’s Day: Alzheimer’s, Dementia, and the Brain Read More »

Biogen Offering Free Alzheimer’s Drug Aduhelm to Patients

Biogen is providing its new Alzheimer’s drug Aduhelm free to some patients because of slow reviews by Medicare. There is a division among doctors about whether Aduhelm, also known as aducanumab, the $56,000-a-year drug helps patients. There is also uncertainty about reimbursement from Medicare. Aduhelm was approved by the U.S. Food and Drug Administration (FDA) …

Biogen Offering Free Alzheimer’s Drug Aduhelm to Patients Read More »

Booster Needed for Delta and Lambda Variants

Scientists may have underestimated the coronavirus. In the beginning, they said mutated versions shouldn’t be much of a problem—until Alpha spiked last fall. Then, Beta made young people sicker. And Gamma reinfected people. Some epidemiologists were cautiously optimistic that the rapid vaccine rollout would tame the variants… until the Delta variant appeared. Delta was first …

Booster Needed for Delta and Lambda Variants Read More »

Unraveling the Mysterious Mutations That Make Delta the Most Transmissible Covid Virus Yet

By Liz Szabo, Kaiser Health News Upon first inspection, the mutations in the highly contagious delta covid variant don’t look that worrisome. For starters, delta has fewer genetic changes than earlier versions of the coronavirus. “When people saw that the epidemic in India was driven by delta, they did not suspect it would be so …

Unraveling the Mysterious Mutations That Make Delta the Most Transmissible Covid Virus Yet Read More »

First Florida Patient to Receive Biogen Aducanumab Infusion

Jeff Gelblum, MD, a board-certified neurologist with First Choice Neurology, the nation’s largest neurology practice, is scheduled to treat the first patient in Florida with Biogen’s Aducanumab (Aduhelm), a monthly infusion treatment for early-stage Alzheimer’s patients. The drug works to decrease amyloid plaque in the brain, which is a marker for Alzheimer’s disease. According to Dr. …

First Florida Patient to Receive Biogen Aducanumab Infusion Read More »

Translate »